Etoposide and Cholecystitis - a phase IV clinical study of FDA data

Summary:

Cholecystitis is reported as a side effect among people who take Etoposide (etoposide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Osteosarcoma.

The phase IV clinical study analyzes which people have Cholecystitis when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Cholecystitis?

Cholecystitis (infection of gallbladder) is found to be associated with 1,185 drugs and 1,217 conditions by eHealthMe. Check the latest studies of Cholecystitis.

On Jul, 18, 2026

77,756 people reported to have side effects when taking Etoposide.
Among them, 91 people (0.12%) have Cholecystitis.

Among these 91 people:

How long have people been on Etoposide when they have Cholecystitis? *

What is the gender of people who have Cholecystitis when taking Etoposide? *

female: 48.75 %
male: 51.25 %

What is the age of people who have Cholecystitis when taking Etoposide? *

What are other drugs people take besides Etoposide? *

What are other side effects people have besides Cholecystitis? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 29 people, 31.87%
Febrile Neutropenia (fever with reduced white blood cells): 25 people, 27.47%
Nausea And Vomiting: 22 people, 24.18%
Thrombocytopenia (decrease of platelets in blood): 20 people, 21.98%
Fever: 15 people, 16.48%
Diarrhea: 15 people, 16.48%
Movement - Uncoordinated: 14 people, 15.38%
Abdominal Pain: 14 people, 15.38%
Hypotension (abnormally low blood pressure): 13 people, 14.29%
Mucosal Inflammation (infection of mucous membrane): 13 people, 14.29%

What are the existing conditions these people have? *

Osteosarcoma (a cancerous (malignant) bone tumour): 13 people, 14.29%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 10.99%
Hodgkin's Lymphoma (cancer originating from white blood cells): 9 people, 9.89%
Pain: 8 people, 8.79%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 6.59%
Multiple Myeloma (cancer of the plasma cells): 5 people, 5.49%
Bone Marrow Disorder: 5 people, 5.49%
Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 4 people, 4.40%
Hodgkin's Disease Stage Iv (cancer originating from white blood cells - stage iv): 4 people, 4.40%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 4 people, 4.40%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and have Cholecystitis?

- Check whether Cholecystitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etoposide:

Etoposide (77,815 reports)

Cholecystitis treatments and more:

Cholecystitis (16,481 reports)

Browse all side effects of Etoposide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis:

Cholecystitis (1,185 drugs)

Browse all the conditions that are associated with Cholecystitis:

Cholecystitis (1,217 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.